Latest news about PainTEQ
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
PainTEQ has been awarded a new patent (US Patent No. 12,121,458) for its LinQ SI Joint Stabilization System, enhancing procedural precision, efficiency, and patient safety through innovative instrument alignment features. This patent strengthens PainTEQ's intellectual property portfolio and reinforces its leadership in minimally invasive SI joint dysfunction treatment[4].
PainTEQ has successfully completed the first in-office LinQ procedure under a new CMS billing code on January 17, 2024, marking a significant advancement in treating sacroiliac joint dysfunction in an outpatient setting[5].
PainTEQ has been awarded two new patents (US Patent No. 11,963,883 and US Patent No. 11,931,053) for its LinQ procedure, covering the design of the LinQ allograft implant and a proprietary single-use joint decorticator tool, enhancing stability, bone growth, and procedural efficiency in treating sacroiliac joint dysfunction[1][3].
Open job positions at PainTEQ
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.